ISSN: 1792-1074

Journal Home

Journal Guideline

Oncology Letters Q3 Unclaimed

Spandidos Publications Greece

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Oncology Letters is a journal indexed in SJR in Oncology and Cancer Research with an H index of 71. It has an SJR impact factor of 0,657 and it has a best quartile of Q3. It has an SJR impact factor of 0,657.

Oncology Letters focuses its scope in these topics and keywords: cancer, cell, expression, factor, breast, patients, case, gene, genes, human, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Cancer Research (Q3) Oncology (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,657

SJR Impact factor

71

H Index

459

Total Docs (Last Year)

3501

Total Docs (3 years)

21202

Total Refs

10278

Total Cites (3 years)

3500

Citable Docs (3 years)

2.78

Cites/Doc (2 years)

46.19

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

European Journal of Cancer Care Q3
Cancer Treatment and Research Communications Q3
ecancermedicalscience Q3
Current Problems in Cancer Q3
Journal of Gastrointestinal Oncology Q3

Compare this journals

Aims and Scope

Best articles by citations

Downregulated long non-coding RNA DREH promotes cell proliferation in hepatitis B virus-associated hepatocellular carcinoma

Expression of Livin and PlGF in human osteosarcoma is associated with tumor progression and clinical outcome

Role of microRNA-4458 in patients with non-small-cell lung cancer

Differential expression of the Na+/I- symporter protein in thyroid cancer and adjacent normal and nodular goiter tissues

Recurrent female adnexal tumor of probable Wolffian origin treated with debulking surgery, imatinib and paclitaxel/carboplatin combination chemotherapy: A case report

Brain metabolic changes in Hodgkin disease patients following diagnosis and during the disease course: An 18F-FDG PET/CT study

Intracellular IL-4 and IFN- gamma expression in iNKT cells from patients with chronic lymphocytic leukemia

LINK-A lncRNA is upregulated in osteosarcoma and regulates migration, invasion and stemness of osteosarcoma cells

Expression of CXC chemokine receptor-4 and forkhead box 3 in neuroblastoma cells and response to chemotherapy

NEDD9 promotes invasion and migration of colorectal cancer cell line HCT116 via JNK/EMT

Sequencing of circulating tumor DNA for dynamic monitoring of gene mutations in advanced non-small cell lung cancer

Bone mesenchymal stem cells differentiate into myofibroblasts in the tumor microenvironment

SHOW MORE ARTICLES

Metastatic B-cell lymphoma masquerading as infectious retinitis and vasculitis

Biliary papillomatosis with malignant transformation: A case report and review of the literature

Cytoskeleton-associated membrane protein'4 is upregulated in tumor tissues and is associated with clinicopathological characteristics and prognosis in hepatocellular carcinoma

Timing of changing therapy from gemcitabine and cisplatin chemotherapy based on real-world data of advanced urothelial carcinoma

EphA2 silencing in nasopharyngeal carcinoma leads to decreased proliferation, invasion and increased sensitization to paclitaxel

Laccase purified from Cerrena unicolor exerts antitumor activity against leukemic cells

Juglone suppresses epithelial-mesenchymal transition in prostate cancer cells via the protein kinase B/glycogen synthase kinase-3beta/Snail signaling pathway

Genistein inhibits A549 human lung cancer cell proliferation via miR-27a and MET signaling

Ultra-early microsurgical treatment within 24 h of SAH improves prognosis of poor-grade aneurysm combined with intracerebral hematoma

SNHG20 serves as a predictor for prognosis and promotes cell growth in oral squamous cell carcinoma

SNHG20/miR-140-5p/NDRG3 axis contributes to 5-fluorouracil resistance in gastric cancer

Outcomes of palliative bowel surgery for malignant bowel obstruction in patients with gynecological malignancy